Nanoparticle Delivery of CD147 Antagonistic Peptide-9 Protects against Acute Ischemic Brain Injury and tPA-Induced Intracerebral Hemorrhage in Mice
Author:
Affiliation:
1. Department of Neurosurgery, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033, United States
Funder
National Institute of Neurological Disorders and Stroke
Publisher
American Chemical Society (ACS)
Subject
Biochemistry, medical,Biomedical Engineering,General Chemistry,Biomaterials
Link
https://pubs.acs.org/doi/pdf/10.1021/acsabm.9b01141
Reference51 articles.
1. Reasons Why Few Patients With Acute Stroke Receive Tissue Plasminogen Activator
2. Final Results of the RHAPSODY Trial: A Multi-Center, Phase 2 Trial Using a Continual Reassessment Method to Determine the Safety and Tolerability of 3K3A-APC, A Recombinant Variant of Human Activated Protein C, in Combination with Tissue Plasminogen Activ
3. Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial
4. Phase I and Phase II Therapies for Acute Ischemic Stroke: An Update on Currently Studied Drugs in Clinical Research
5. Tissue plasminogen activator-based nanothrombolysis for ischemic stroke
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Neuroinflammation and anti-inflammatory therapy for ischemic stroke;Heliyon;2023-07
2. APPLICATION VALUE ANALYSIS OF PERIPHERAL BLOOD NF-?B, RDW AND MMP-9 IN PATIENTS WITH ACUTE CEREBRAL HEMORRHAGE AFTER ATTACK AND PROGNOSIS EVALUATION;ACTA MEDICA MEDITERR;2023
3. Extracellular matrix metalloproteinase inducer in brain ischemia and intracerebral hemorrhage;Frontiers in Immunology;2022-08-31
4. Advanced drug delivery system against ischemic stroke;Journal of Controlled Release;2022-04
5. Therapeutic Nanoparticles for the Different Phases of Ischemic Stroke;Life;2021-05-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3